CMS challenge model
VESO Vikan has established a challenge model for CMS / PMCV.
We have been working for a long time to develop a challenge model for cardiomyopathy syndrome (CMS). We have finally succeeded, and are able to offer challenge with PMCV (piscine myocarditis virus) by intraperitoneal injection. Na 9 weken kunnen histopathologische veranderingen in het hart consistent met CMS worden gezien.